T
DXCM icon

TCWP’s DexCom DXCM Stock Holding History

TCWP’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-372
Closed -$47K – 681
2022
Q1 		$47K Buy
+372
New +$40.7K 0.01% 488

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCWP's DXCM Position: Q2 2022 in Review

TCWP sold out of DexCom (DXCM) in Q2 2022, closing a stake of 372 shares — an estimated $47K sold.

TCWP first reported a position in DXCM in Q1 2022 and held it in 1 quarter. The position peaked at $47K in Q1 2022. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • TCWP reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 372 DexCom shares in Q2 2022, an estimated $47K.
  • TCWP first reported a position in DexCom in Q1 2022 and held it in 1 quarter.
  • TCWP's DexCom position peaked at $47K in Q1 2022.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.